B-cell malignancies

🏥2Companies

❤️1Engagements

Companies in B-cell malignancies

Note, this image was autogenerated by Syggy based on what we know about the company. It is not an official company publication.

Schrödinger

IPO

New York, New York, USA

Schrödinger is an international scientific software and biotechnology company, founded in 1990, developing computational tools for drug discovery and materials science. Its phys...

...more

Business ModelB2B (Software licensing) and a drug discovery model, advancing preclinical and clinical programs internally and through collaborations. SaaS is implied through platform licensing.

Core Techphysics-based computational platform

Funding$394.2M

Founded1990

Drug Discovery/Development

Get Involved in Schrödinger

Recursion

Public

Salt Lake City, Utah, United States

Recursion is a drug discovery company that utilizes automation and machine learning.

Business ModelB2B (partnerships with pharmaceutical companies for drug development, licensing, royalties, milestone payments), B2C (future drug sales from internal development)

Core Tech"Recursion Operating System (OS)," an end-to-end AI-drive...

Funding$1.0B

Founded2013

Drug Discovery/Development

Too Big!

Get Involved in Recursion